Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daptomycin plus fosfomycin vs daptomycin for MRSA bacteremia
NCT01898338Phase 3Completed
- Start
- Dec 2013
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fosfomycin in Staphylococcus aureus bacteremia (SAB). Started Dec 2013; status: completed.
02
Drugs
fosfomycin
03
Conditions
Staphylococcus aureus bacteremia (SAB)
Beyond the preview
Go deeper on NCT01898338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01898338.